Poxel SA announced the addition of Janice Bourque, Managing Director of Hercules Technology Growth Capital, and Pierre Legault, President and CEO of Nephrogenex Inc, to its Board of Directors. Both appointments were approved by Poxel's shareholders at the Annual Shareholder Meeting held in Paris on January 29, 2016. Janice Bourque has been Managing Director, Life Sciences at Hercules Technology Growth Capital, a technology and life science specialty finance company, since 2010.

Prior to this, she was a consultant at Commons Capital where she advised and provided strategic corporate investor fundraising. From 2005 to 2009 she was the Senior Vice President and Group Head-Life Sciences at Comerica Bank in Dallas, Texas. Janice was also President and CEO of the Massachusetts Biotechnology Council.

Pierre Legault joins Poxel with over 35 years of experience working in the pharmaceutical and biotechnology industry. Since 2012, he has been the Executive Chairman and later became President and CEO of NephroGenex. From 2010 to 2012, he was President and CEO of Prosidion Ltd. In 2009/2010, he was Executive Vice President, Chief Financial Officer and Treasurer of OSI Pharmaceuticals.

From 2006 to 2007, Pierre was President of Eckerd Pharmacies.